Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-World Effectiveness of the R21/Matrix-M Malaria Vaccine in Children in Burkina Faso and Uganda

NCT07749911 is registered in ClinicalTrials.gov with Clinton Health Access Initiative Inc. as lead sponsor.

NCT NCT07749911
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07749911 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-World Effectiveness of the R21/Matrix-M Malaria Vaccine in Children in Burkina Faso and Uganda
Lead sponsor
Clinton Health Access Initiative Inc.
Phase
Observational
Overall status
Recruiting
Start date
July 14, 2026
Completion date
August 31, 2027
Enrollment
20,000 (estimated)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

malaria, plasmodium falciparum malaria